GreenGuru Pulse · Global
Medical cannabis intelligence, country by country.
Explore the world first. Switch between medical access, patient intelligence, adult-use status and travel-with-prescription rules without pretending those questions mean the same thing.
Global patient counter
Estimated patients represented by GreenGuru
The counter moves only when a single source-backed patient observation passes the comparability gate. Estimate ranges remain ranges and never get collapsed into invented precision.
Explore the world
Choose a country. Change the question.
Medical access, adult-use legality and patient-data confidence are separate layers. A country can have lawful medical access even when no comparable national patient count exists.
Boundary geometry: Natural Earth 1:50m Admin-0 countries · Natural Earth 1, pinned commit ca96624a. Legal status and patient intelligence are governed separately from map geometry.
Why totals and colours differ
Legal access is not a patient count.
Different countries measure different things. GreenGuru stores each observation with its own definition and does not silently treat registrations, prescriptions, approvals or authorisations as equivalent to unique patients.
The total may move up or down when an underlying country observation is added, revised, withdrawn or reclassified. The counter must never simulate real-time patient growth between source updates.
Patient intelligence
The governed patient records behind the counter.
Official figures, estimate ranges and non-comparable measures remain visibly different. Open a record to inspect the exact definition and source trail.
United KingdomRegulated medical accessEstimated
The best current UK-wide figure GreenGuru holds is an industry estimate of 60,000–75,000 active patients. Official NHSBSA data separately identified 880 NHS patients receiving licensed cannabis-based medicines in England during February 2024 to January 2025, while DHSC states that patient information is not routinely collected for private prescriptions. These measures are not equivalent.
Definition: Industry research estimate of active UK medical cannabis patients published by the Cannabis Industry Council, based on research from Plantz and Cannavec.ai.
Global counter: Excluded — This is a published estimate range rather than a single national administrative patient count. GreenGuru displays the range but does not invent a midpoint for the global counter.
CanadaRegulated medical accessLimited / unverified
Canada publishes strong official access data, but the main seller-registration figure is not a deduplicated patient count and is therefore excluded from GreenGuru's global patient total.
Definition: Registrations with federally licensed sellers that were active at the end of the month.
Global counter: Excluded — Health Canada states that a patient can be registered with more than one licensed seller, so this figure cannot be treated as a unique patient count.
AustraliaRegulated medical accessNo reliable data
The TGA explicitly says it does not publish the number of patients accessing medicinal cannabis and that SAS approvals and Authorised Prescriber notifications do not equal patient numbers.
GermanyRegulated medical accessNo reliable data
Current federal guidance confirms regulated medical access but does not provide a public national unique-patient total suitable for the GreenGuru counter.
IsraelPermit-based regulated medical accessEstimated
The Knesset Health Committee reported 128,000 current cannabis patients based on health-fund data. GreenGuru marks this estimated rather than verified because the figure is reported through the committee record rather than a live Ministry patient dataset.
Definition: Knesset Health Committee reporting of health-fund data stating that 128,000 patients were currently using cannabis.
Global counter: Included
Accessible evidence view
Governed map coverage
This table is the non-map equivalent of the current legal/access and patient-intelligence coverage.
| Country | Medical access | Adult-use | Patient confidence | Held patient measure |
|---|---|---|---|---|
| United Kingdom | Regulated medical access | Non-medical cannabis remains prohibited | Estimated | 60,000–75,000 estimated active medical cannabis patients |
| Canada | Regulated medical access | Legal regulated adult access | Limited / unverified | 161,267 active medical client registrations with federally licensed sellers |
| Germany | Regulated medical access | Limited non-commercial adult possession, home grow and cultivation associations | No reliable data | No governed national patient figure yet |
| Australia | Regulated medical access through prescription pathways | Not yet governed | No reliable data | No governed national patient figure yet |
| Israel | Permit-based regulated medical access | Not yet governed | Estimated | 128,000 current medical cannabis patients |
| Switzerland | Prescription medical access | Non-medical use remains prohibited outside authorised pilot trials | No governed patient record | No governed national patient figure yet |
| New Zealand | Prescription access under the Medicinal Cannabis Scheme | Not yet governed | No governed patient record | No governed national patient figure yet |
| Uruguay | Regulated medical and therapeutic cannabis access | State-regulated adult-use framework | No governed patient record | No governed national patient figure yet |
| Malta | Not yet governed | Responsible-use framework with limited non-commercial access | No governed patient record | No governed national patient figure yet |
| Luxembourg | National medical cannabis programme | Limited legal non-medical access experiment | No governed patient record | No governed national patient figure yet |
Coverage and evidence boundary
Global Pulse is live with an initial governed evidence set and expanding coverage; it is not an exhaustive worldwide legal or patient-data service. Medical access, adult-use legality, patient-count confidence and travel/import rules are governed separately. A country's domestic cannabis laws never imply permission for a UK patient to cross its border carrying prescribed cannabis, and border requirements should be rechecked with the destination authority shortly before travel.